Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 70-year-old white female presented approximately 24 h after ingesting three 475 mg tablets (1.425 g) of mercuric chloride in a
suicide attempt
. Acute renal failure necessitated the initiation of haemodialysis approximately 4 d after the ingestion. Treatment with
BAL
(2,3-dimercaptopropanol) resulted in only small increases in mercury output into dialysate. A new procedure involving the extracorporeal infusion of the chelating agent dimercaptosuccinic acid (DMSA) into the arterial blood line during haemodialysis was initiated. This procedure of Extracorporeal Regional Complexing Haemodialysis (ERCH) had been effective in increasing methylmercury removal in patients poisoned by contaminated grain. The first DMSA-ERCH procedure was performed 6 d after poisoning. There was a dramatic increase in mercury output into the dialysate. During three treatment sessions of 80 min each, 1189 micrograms of mercury were removed from the patient. The dialysed mercury represented the only mercury output since the patient was anuric and not producing faeces. DMSA-ERCH appears to be much more effective than
BAL
and haemodialysis in the treatment of acute inorganic mercury poisoning. The long interval between poisoning and initiation of treatment probably contributed to the patients ultimate demise, 28 d after poisoning. Efficacy of the DMSA-ERCH procedure for inorganic mercury poisoning is likely to be improved as the interval between exposure and treatment is reduced.
...
PMID:Extracorporeal regional complexing haemodialysis treatment of acute inorganic mercury intoxication. 216 15
A 29-year-old man was found unresponsive a few minutes after self-injecting undetermined amounts of potassium cyanide and sodium arsenite intravenously in a
suicide attempt
. Treatment with the Lilly Cyanide Antidote kit rapidly resolved the initial coma, despite a whole blood cyanide level of 4.4 micrograms/mL. A 12-hour urine arsenic collection begun on admission showed 10,065 micrograms arsenic/12 hr. The patient received intramuscular
BAL
initially, which was followed by two ten-day courses of oral D-penicillamine. Complications included upper gastrointestinal tract bleeding requiring transfusion, transient elevations of liver function tests, self-limited complaints of decreased vision with conjunctival hyperemia and photophobia, and an abscess at the injection site. Although specific antidote therapy completely resolved the cyanide toxicity, early and prolonged arsenic chelation did not prevent a mild sensory peripheral neuropathy from developing with onset about 17 days after self-injection.
...
PMID:Cyanide and arsenic poisoning by intravenous injection. 253 98
This paper reports on a case of attempted suicide by the rare means of prolonged inhalation of fumes from heated mercury. The patient developed symptoms of acute intoxication over a period of 4 to 24 hours after the
suicide attempt
. This phase consisted of pulmonary, intestinal, psychopathological and neurological signs, persisting at varying intensities for approximately 3 weeks; it was succeeded by a chronic phase with peripheral nerve changes, initially of the axonal type, but later also showing signs of demyelinisation. Furthermore, a pronounced organic brain syndrome developed. The psychopathological, somatic and detoxification results are presented, whereby the symptomatology worsened even after substantial mercury excretion. A follow-up 4 months after the acute episode confirmed the chronicity of the central and peripheral nervous impairment. Therapeutic measures (
BAL
and aminopenicillin) are discussed; the use of these even 13 weeks after exposure caused massive mercury excretion.
...
PMID:[Poisoning with elementary mercury: attempted suicide by inhalation of vapors from the heated metal]. 660 70